Edition:
United Kingdom

Dermira Inc (DERM.OQ)

DERM.OQ on NASDAQ Stock Exchange Global Select Market

10.93USD
6:32pm BST
Change (% chg)

$-0.62 (-5.37%)
Prev Close
$11.55
Open
$11.18
Day's High
$11.48
Day's Low
$10.66
Volume
233,019
Avg. Vol
408,718
52-wk High
$15.47
52-wk Low
$6.00

About

Dermira, Inc. is a biopharmaceutical company. The Company is focused on the development of therapeutic solutions in medical dermatology to treat skin conditions, such as hyperhidrosis, psoriasis and acne. Its portfolio includes three late-stage product candidates: Cimzia (certolizumab pegol), glycopyrronium tosylate and... (more)

Overall

Beta: 1.40
Market Cap(Mil.): $602.21
Shares Outstanding(Mil.): 52.14
Dividend: --
Yield (%): --

Financials

  DERM.OQ Industry Sector
P/E (TTM): -- 109.48 62.40
EPS (TTM): -5.27 -- --
ROI: -58.21 7.96 11.78
ROE: -315.11 8.11 12.61

BRIEF-Dermira Inc Entered Into First Amendment To License Agreement With Roche

* DERMIRA INC - ENTERED INTO FIRST AMENDMENT TO LICENSE AGREEMENT WITH ROCHE

28 Feb 2019

Earnings vs. Estimates